A detailed history of Innovis Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Innovis Asset Management LLC holds 9,706 shares of ABBV stock, worth $1.62 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
9,706
Previous 11,793 17.7%
Holding current value
$1.62 Million
Previous $1.59 Billion 8.94%
% of portfolio
0.56%
Previous 0.59%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $278,802 - $322,754
-2,087 Reduced 17.7%
9,706 $1.45 Billion
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $12,853 - $15,995
-97 Reduced 0.82%
11,793 $1.59 Billion
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $169,049 - $194,685
-1,169 Reduced 8.95%
11,890 $1.89 Billion
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $1.81 Million - $2.17 Million
13,059 New
13,059 $2.11 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Innovis Asset Management LLC Portfolio

Follow Innovis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innovis Asset Management LLC with notifications on news.